by A catheter related blood stream infection (CRBSI) is a serious infection that develops when bacteria or germs enter the bloodstream through a central line catheter. These catheters are hollow, flexible tubes that are placed into large veins for patients who need long-term intravenous treatments, such as chemotherapy or intravenous feeding. Catheters provide an easy way of giving drugs, fluids, or nutrients when oral administration is impossible. However, they can cause infections if not inserted or cared for properly. Risks associated with CRBSI include sepsis, extended hospital stays, permanent disability, and in some cases, even death. The introduction of antimicrobial-coated catheters is expected to significantly reduce the risk of these infections.
The global catheter related blood stream infection market is estimated to be valued at US$ 1875.01 Mn in 2024 and is expected to exhibit a CAGR of 6.2% over the forecast period 2024 to 2031.
Key players operating in the catheter related blood stream infection market are BASF SE, Croda International plc, Emery Oleochemicals, Haihang Industry Co., Ltd, Jiangsu Senxuan Pharmaceutical and Chemical Co., Ltd., Matrica S.p.A., Nantong Hengxing Electronic Materials Co., Ltd., Nantong Jinghua Pharmaceutical Co., Ltd., Wufeng Chicheng Biotech Co., Ltd., and Xi’an Sonwu Biotech Co., Ltd.
Key Takeaways
Key players – Key players operating in The Catheter Related Blood Stream Infection Market are BASF SE, Croda International plc, Emery Oleochemicals, Haihang Industry Co., Ltd, Jiangsu Senxuan Pharmaceutical and Chemical Co., Ltd., Matrica S.p.A., Nantong Hengxing Electronic Materials Co., Ltd., Nantong Jinghua Pharmaceutical Co., Ltd., Wufeng Chicheng Biotech Co., Ltd., and Xi’an Sonwu Biotech Co., Ltd.
Key opportunities – Rising healthcare expenditure in developing regions and growing demand for long-term vascular access are expected to create new opportunities.
Technological advancements – Innovations in antimicrobial coatings for catheters such as silver, minocycline and rifampin coatings have significantly lowered the risk of infections.
Market drivers
Growing geriatric population – Age is a major risk factor for central line-associated bloodstream infections. With rise in life expectancy globally, the elderly population is expected to increase dramatically, driving the need for long-term catheterization and associated infection control measures. Initiatives by governments and healthcare agencies to promote antimicrobial coated catheters will also aid market growth.
Current challenges in the Catheter Related Blood Stream Infection Market
The catheter related blood stream infection market is facing numerous challenges currently. One of the major challenge is increasing prevalence of hospital acquired infections due to improper insertion and maintenance of catheters. Poor adherence to clinical guidelines for insertion and maintenance of catheters is another challenge. Lack of awareness about proper hygiene practices related to catheters especially in developing regions is aggravating the problem of catheter related infections. Shortage of skilled professionals for catheter insertion and maintenance is another area of concern.
SWOT Analysis
Strength: Safe and easy to use catheters with antimicrobial coatings help prevent infections. Wide availability of innovative products.
Weakness: High cost of advanced catheters limits adoption in low income regions. Adherence to clinical guidelines remains a challenge.
Opportunity: Rising awareness programs can help address improper practices. Increased spending on healthcare infra in emerging markets.
Threats: Threat from generic competitors. Stringent regulatory approvals delay market entry of new products.
Geographical regions where market concentration is high in terms of value include North America and Europe. This is because of advanced healthcare systems and high adoption of novel technologies in these regions. Another region of high market concentration is East Asia led by countries like China, Japan and South Korea.
The catheter related blood stream infection market is witnessing fastest growth in South Asia and Africa region. This is due to improving access to healthcare facilities and increasing healthcare spending in countries like India, Indonesia, Nigeria and South Africa. Rising awareness about importance of hygiene and initiatives by global players are also supporting growth of the market in these emerging economies.
